Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arcion Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Arcion Therapeutics

Arcion Therapeutics

Inactive

US-based Arcion Therapeutics develops treatments for neuropathic conditions and various pain forms.

HQ
Baltimore, MD, US
Founded
2007
Overview
Compare
Fundraising
Employees
Website

Arcion Therapeutics focuses on developing innovative treatments for neuropathic conditions and various forms of pain. The company's primary mission is to address unmet medical needs in pain management, with a particular emphasis on painful diabetic neuropathy and post-herpetic neuralgia. Based in the United States, Arcion Therapeutics aims to improve the quality of life for patients suffering from moderate to severe pain conditions.

The company's research and development efforts are directed towards creating novel therapeutics that target specific pain pathways. Arcion Therapeutics strives to advance the field of pain management by offering potentially more effective and targeted treatment options for patients with challenging neuropathic conditions.

Arcion Therapeutics - Similar Companies

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

Arcuate Therapeutics logo

Arcuate Therapeutics

4e Therapeutics logo

4e Therapeutics

Nocion Therapeutics logo

Nocion Therapeutics

nociontx.com

Centrexion Therapeutics logo

Centrexion Therapeutics

Sarentis Therapeutics logo

Sarentis Therapeutics

Neuropathix logo

Neuropathix

neuropathix.com

Aiko Biotechnology logo

Aiko Biotechnology

Doloromics logo

Doloromics

doloromics.com

Axerion Therapeutics logo

Axerion Therapeutics

Xdynia logo

Xdynia

Pacira BioSciences logo

Pacira BioSciences

pacira.com

Trigemina logo

Trigemina

Vapogenix logo

Vapogenix

vapogenix.com

Thermaquil logo

Thermaquil

thermaquil.com

Arcion Therapeutics - Quick Facts

Who are Arcion Therapeutics' competitors?

Companies similar to Arcion Therapeutics include NeuroTherapeutics Pharma, Arcuate Therapeutics, 4e Therapeutics and Nocion Therapeutics.

When was Arcion Therapeutics founded?

Arcion Therapeutics was founded in 2007.

Where is Arcion Therapeutics' headquarters located?

Arcion Therapeutics' headquarters is located in Baltimore, MD, US.

When was Arcion Therapeutics' last funding round?

Arcion Therapeutics' most recent funding round was for $1.5M (USD) in October 2012.

How much has Arcion Therapeutics raised to-date?

As of Oct 2, 2012, Arcion Therapeutics has raised a total of $17M (USD).

Arcion Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
Customer
  • Consumers
Main Product
  • Pain Treatments
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified